2024-2030 Global Diuretic Drugs Industry Research & Trends Analysis Report
According to latest Research, the global market for Diuretic Drugs should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
China Diuretic Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
The United States Diuretic Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
In terms of type, Carbonic Anhydrase Inhibitors segment holds a share about % in 2023 and will reach % in 2029; while in terms of application, Hospital Pharmacies has a share approximately % in 2023 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Diuretic Drugs include AstraZeneca, Aurobindo Pharma, Glaxosmithkline, Meda Pharmaceuticals, Roche, Bayer, Bristol-Myers Squibb Compan, yCipla and F.Hoffmann-La Roche, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Diuretic Drugs. Report Highlights:
(1) Global Diuretic Drugs market size (sales volume & revenue), history data from 2019-2024 and forecast data from 2024 to 2030.
(2) Global Diuretic Drugs market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(3) China Diuretic Drugs market competitive situation, sales, revenue, price and market share, from 2019 to 2024.
(4) Global Diuretic Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Diuretic Drugs segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Diuretic Drugs, capacity, production and trends.
(7) Diuretic Drugs industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Carbonic Anhydrase Inhibitors
Loop Diuretics
Osmotic Diuretics
Potassium-sparing Diuretics
Thiazide Diuretics
Market segment by application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
AstraZeneca
Aurobindo Pharma
Glaxosmithkline
Meda Pharmaceuticals
Roche
Bayer
Bristol-Myers Squibb Compan
yCipla
F.Hoffmann-La Roche
Fresenius Kabi
GSK plc
Hikma Pharmaceuticals PLC
Mylan
Novartis Pharmaceuticals
Pfizer
Sanofi
Teva Pharmaceutical lndustries
1 Market Overview
1.1 Diuretic Drugs Definition
1.2 Global Diuretic Drugs Market Size and Forecast
1.2.1 By Revenue, Global Diuretic Drugs Market Size, 2019-2030
1.2.2 By Sales Volume, Global Diuretic Drugs Market Size, 2019-2030
1.2.3 Global Diuretic Drugs Price Trend, 2019-2030
1.3 China Diuretic Drugs Market Size and Forecast
1.3.1 By Revenue, China Diuretic Drugs Market Size, 2019-2030
1.3.2 By Sales Volume, China Diuretic Drugs Market Size, 2019-2030
1.3.3 China Diuretic Drugs Price Trend, 2019-2030
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Diuretic Drugs Share in Global Market, 2019-2030
1.4.2 By Sales Volume, China Diuretic Drugs Share in Global Market, 2019-2030
1.4.3 Diuretic Drugs Market Size: China VS Global, 2019-2030
1.5 Diuretic Drugs Market Dynamics
1.5.1 Diuretic Drugs Market Drivers
1.5.2 Diuretic Drugs Market Restraints
1.5.3 Diuretic Drugs Industry Trends
1.5.4 Diuretic Drugs Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Diuretic Drugs Revenue by Company, 2019-2024
2.2 Global Diuretic Drugs Sales Volume by Company, 2019-2024
2.3 Global Diuretic Drugs Price by Company, 2019-2024
2.4 Global Diuretic Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Diuretic Drugs Concentration Ratio
2.6 Global Diuretic Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Diuretic Drugs Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Diuretic Drugs Revenue by Company, 2019-2024
3.2 China Diuretic Drugs Sales Volume by Company, 2019-2024
3.3 China Diuretic Drugs Diuretic Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Diuretic Drugs Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)
3.5 Chinese Local Players, Diuretic Drugs Domestic VS Export
3.6 China Market, Diuretic Drugs Import & Export
3.6.1 China Market, Diuretic Drugs Import & Export, 2019-2030
3.6.2 China Diuretic Drugs Import & Export Trends
3.6.3 Main Sources of China Diuretic Drugs Import
3.6.4 Export Destination of China Diuretic Drugs
4 Diuretic Drugs Production by Region
4.1 Global Diuretic Drugs Capacity, Production and Capacity Utilization, 2019-2030
4.2 Global Geographic Distribution of Diuretic Drugs Manufacturers
4.3 Global Major Manufacturers, Diuretic Drugs Capacity Expansion and Future Plans
4.4 Global Diuretic Drugs Capacity by Region
4.5 Global Diuretic Drugs Production by Region
4.5.1 Global Diuretic Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030
4.5.2 Global Diuretic Drugs Production by Region, 2019-2024
4.5.3 Global Diuretic Drugs Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Diuretic Drugs Industry Chain
5.2 Diuretic Drugs Upstream Analysis
5.2.1 Diuretic Drugs Core Raw Materials
5.2.2 Main Manufacturers of Diuretic Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Diuretic Drugs Production Mode
5.6 Diuretic Drugs Procurement Model
5.7 Diuretic Drugs Industry Sales Model and Sales Channels
5.7.1 Diuretic Drugs Sales Model
5.7.2 Diuretic Drugs Typical Distributors
6 Sights by Type
6.1 Diuretic Drugs Classification
6.1.1 Carbonic Anhydrase Inhibitors
6.1.2 Loop Diuretics
6.1.3 Osmotic Diuretics
6.1.4 Potassium-sparing Diuretics
6.1.5 Thiazide Diuretics
6.2 By Type, Global Diuretic Drugs Market Size & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Diuretic Drugs Revenue, 2019-2030
6.4 By Type, Global Diuretic Drugs Sales Volume, 2019-2030
6.5 By Type, Global Diuretic Drugs Price, 2019-2030
7 Sights by Application
7.1 Diuretic Drugs Segment by Application
7.1.1 Hospital Pharmacies
7.1.2 Retail Pharmacies
7.1.3 Online Pharmacies
7.2 By Application, Global Diuretic Drugs Market Size & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Diuretic Drugs Revenue, 2019-2030
7.4 By Application, Global Diuretic Drugs Sales Volume, 2019-2030
7.5 By Application, Global Diuretic Drugs Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Diuretic Drugs Market Size, 2019 VS 2024 VS 2030
8.2 By Region, Global Diuretic Drugs Revenue, 2019-2030
8.3 By Region, Global Diuretic Drugs Sales Volume, 2019-2030
8.4 North America
8.4.1 North America Diuretic Drugs Market Size & Forecasts, 2019-2030
8.4.2 By Country, North America Diuretic Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Diuretic Drugs Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Diuretic Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Diuretic Drugs Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Diuretic Drugs Market Size Market Share
8.7 South America
8.7.1 South America Diuretic Drugs Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Diuretic Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Diuretic Drugs Market Size & CAGR，2019 VS 2024 VS 2030
9.2 By Country, Global Diuretic Drugs Revenue, 2019-2030
9.3 By Country, Global Diuretic Drugs Sales Volume, 2019-2030
9.4 U.S.
9.4.1 U.S. Diuretic Drugs Market Size, 2019-2030
9.4.2 By Company, U.S. Diuretic Drugs Sales Volume Market Share, 2023
9.4.3 By Type, U.S. Diuretic Drugs Market Size, Share, 2024 VS 2030
9.4.4 By Application, U.S. Diuretic Drugs Market Size, Share, 2024 VS 2030
9.5 Europe
9.5.1 Europe Diuretic Drugs Market Size, 2019-2030
9.5.2 By Company, Europe Diuretic Drugs Sales Volume Market Share, 2023
9.5.3 By Type, Europe Diuretic Drugs Market Size, Share, 2024 VS 2030
9.5.4 By Application, Europe Diuretic Drugs Market Size, Share, 2024 VS 2030
9.6 China
9.6.1 China Diuretic Drugs Market Size, 2019-2030
9.6.2 By Company, China Diuretic Drugs Sales Volume Market Share, 2023
9.6.3 By Type, China Diuretic Drugs Market Size, Share, 2024 VS 2030
9.6.4 By Application, China Diuretic Drugs Market Size, Share, 2024 VS 2030
9.7 Japan
9.7.1 Japan Diuretic Drugs Market Size, 2019-2030
9.7.2 By Company, Japan Diuretic Drugs Sales Volume Market Share, 2023
9.7.3 By Type, Japan Diuretic Drugs Market Size, Share, 2024 VS 2030
9.7.4 By Application, Japan Diuretic Drugs Market Size, Share, 2024 VS 2030
9.8 South Korea
9.8.1 South Korea Diuretic Drugs Market Size, 2019-2030
9.8.2 By Company, South Korea Diuretic Drugs Sales Volume Market Share, 2023
9.8.3 By Type, South Korea Diuretic Drugs Market Size, Share, 2024 VS 2030
9.8.4 By Application, South Korea Diuretic Drugs Market Size, Share, 2024 VS 2030
9.9 Southeast Asia
9.9.1 Southeast Asia Diuretic Drugs Market Size, 2019-2030
9.9.2 By Company, Southeast Asia Diuretic Drugs Sales Volume Market Share, 2023
9.9.3 By Type, Southeast Asia Diuretic Drugs Market Size, Share, 2024 VS 2030
9.9.4 By Application, Southeast Asia Diuretic Drugs Market Size, Share, 2024 VS 2030
9.10 India
9.10.1 India Diuretic Drugs Market Size, 2019-2030
9.10.2 By Company, India Diuretic Drugs Sales Volume Market Share, 2023
9.10.3 By Type, India Diuretic Drugs Market Size, Share, 2024 VS 2030
9.10.4 By Application, India Diuretic Drugs Market Size, Share, 2024 VS 2030
9.11 Middle East & Asia
9.11.1 Middle East & Asia Diuretic Drugs Market Size, 2019-2030
9.11.2 By Company, Middle East & Asia Diuretic Drugs Sales Volume Market Share, 2023
9.11.3 By Type, Middle East & Asia Diuretic Drugs Market Size, Share, 2024 VS 2030
9.11.4 By Application, Middle East & Asia Diuretic Drugs Market Size, Share, 2024 VS 2030
10 Manufacturers Profile
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.1.2 AstraZeneca Diuretic Drugs Models, Specifications and Application
10.1.3 AstraZeneca Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.1.4 AstraZeneca Company Profile and Main Business
10.1.5 AstraZeneca Recent Developments
10.2 Aurobindo Pharma
10.2.1 Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
10.2.2 Aurobindo Pharma Diuretic Drugs Models, Specifications and Application
10.2.3 Aurobindo Pharma Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.2.4 Aurobindo Pharma Company Profile and Main Business
10.2.5 Aurobindo Pharma Recent Developments
10.3 Glaxosmithkline
10.3.1 Glaxosmithkline Company Information, Head Office, Market Area and Industry Position
10.3.2 Glaxosmithkline Diuretic Drugs Models, Specifications and Application
10.3.3 Glaxosmithkline Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Glaxosmithkline Company Profile and Main Business
10.3.5 Glaxosmithkline Recent Developments
10.4 Meda Pharmaceuticals
10.4.1 Meda Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.4.2 Meda Pharmaceuticals Diuretic Drugs Models, Specifications and Application
10.4.3 Meda Pharmaceuticals Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Meda Pharmaceuticals Company Profile and Main Business
10.4.5 Meda Pharmaceuticals Recent Developments
10.5 Roche
10.5.1 Roche Company Information, Head Office, Market Area and Industry Position
10.5.2 Roche Diuretic Drugs Models, Specifications and Application
10.5.3 Roche Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Roche Company Profile and Main Business
10.5.5 Roche Recent Developments
10.6 Bayer
10.6.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.6.2 Bayer Diuretic Drugs Models, Specifications and Application
10.6.3 Bayer Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Bayer Company Profile and Main Business
10.6.5 Bayer Recent Developments
10.7 Bristol-Myers Squibb Compan
10.7.1 Bristol-Myers Squibb Compan Company Information, Head Office, Market Area and Industry Position
10.7.2 Bristol-Myers Squibb Compan Diuretic Drugs Models, Specifications and Application
10.7.3 Bristol-Myers Squibb Compan Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.7.4 Bristol-Myers Squibb Compan Company Profile and Main Business
10.7.5 Bristol-Myers Squibb Compan Recent Developments
10.8 yCipla
10.8.1 yCipla Company Information, Head Office, Market Area and Industry Position
10.8.2 yCipla Diuretic Drugs Models, Specifications and Application
10.8.3 yCipla Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.8.4 yCipla Company Profile and Main Business
10.8.5 yCipla Recent Developments
10.9 F.Hoffmann-La Roche
10.9.1 F.Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position
10.9.2 F.Hoffmann-La Roche Diuretic Drugs Models, Specifications and Application
10.9.3 F.Hoffmann-La Roche Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.9.4 F.Hoffmann-La Roche Company Profile and Main Business
10.9.5 F.Hoffmann-La Roche Recent Developments
10.10 Fresenius Kabi
10.10.1 Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
10.10.2 Fresenius Kabi Diuretic Drugs Models, Specifications and Application
10.10.3 Fresenius Kabi Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.10.4 Fresenius Kabi Company Profile and Main Business
10.10.5 Fresenius Kabi Recent Developments
10.11 GSK plc
10.11.1 GSK plc Company Information, Head Office, Market Area and Industry Position
10.11.2 GSK plc Diuretic Drugs Models, Specifications and Application
10.11.3 GSK plc Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.11.4 GSK plc Company Profile and Main Business
10.11.5 GSK plc Recent Developments
10.12 Hikma Pharmaceuticals PLC
10.12.1 Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
10.12.2 Hikma Pharmaceuticals PLC Diuretic Drugs Models, Specifications and Application
10.12.3 Hikma Pharmaceuticals PLC Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.12.4 Hikma Pharmaceuticals PLC Company Profile and Main Business
10.12.5 Hikma Pharmaceuticals PLC Recent Developments
10.13 Mylan
10.13.1 Mylan Company Information, Head Office, Market Area and Industry Position
10.13.2 Mylan Diuretic Drugs Models, Specifications and Application
10.13.3 Mylan Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.13.4 Mylan Company Profile and Main Business
10.13.5 Mylan Recent Developments
10.14 Novartis Pharmaceuticals
10.14.1 Novartis Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
10.14.2 Novartis Pharmaceuticals Diuretic Drugs Models, Specifications and Application
10.14.3 Novartis Pharmaceuticals Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.14.4 Novartis Pharmaceuticals Company Profile and Main Business
10.14.5 Novartis Pharmaceuticals Recent Developments
10.15 Pfizer
10.15.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.15.2 Pfizer Diuretic Drugs Models, Specifications and Application
10.15.3 Pfizer Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.15.4 Pfizer Company Profile and Main Business
10.15.5 Pfizer Recent Developments
10.16 Sanofi
10.16.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.16.2 Sanofi Diuretic Drugs Models, Specifications and Application
10.16.3 Sanofi Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.16.4 Sanofi Company Profile and Main Business
10.16.5 Sanofi Recent Developments
10.17 Teva Pharmaceutical lndustries
10.17.1 Teva Pharmaceutical lndustries Company Information, Head Office, Market Area and Industry Position
10.17.2 Teva Pharmaceutical lndustries Diuretic Drugs Models, Specifications and Application
10.17.3 Teva Pharmaceutical lndustries Diuretic Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024
10.17.4 Teva Pharmaceutical lndustries Company Profile and Main Business
10.17.5 Teva Pharmaceutical lndustries Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Diuretic Drugs Market Size & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Diuretic Drugs Market Restraints
Table 3. Diuretic Drugs Market Trends
Table 4. Diuretic Drugs Industry Policy
Table 5. Global Diuretic Drugs Revenue by Company, 2019-2024, US$ million
Table 6. Global Diuretic Drugs Revenue Market Share by Company, 2019-2024
Table 7. Global Diuretic Drugs Sales Volume by Company, 2019-2024, (K Units)
Table 8. Global Diuretic Drugs Sales Volume Market Share by Company, 2019-2024
Table 9. Global Diuretic Drugs Price by Company, 2019-2024, (US$/Unit)
Table 10. Global Diuretic Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Diuretic Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Diuretic Drugs Manufacturers Product Type
Table 13. China Diuretic Drugs Revenue by Company, 2019-2024, US$ million
Table 14. China Diuretic Drugs Revenue Market Share by Company, 2019-2024
Table 15. China Diuretic Drugs Sales Volume by Company, 2019-2024, (K Units)
Table 16. China Diuretic Drugs Sales Volume Market Share by Company, 2019-2024
Table 17. China Market, Diuretic Drugs Production, Sales, Import and Export, 2019-2030, (K Units)
Table 18. China Diuretic Drugs Import & Export Trends
Table 19. Main Sources of China Diuretic Drugs Import
Table 20. Export Destination of China Diuretic Drugs
Table 21. Global Headquarters and Manufacturing Base of Diuretic Drugs Manufacturers
Table 22. Global Major Manufacturers, Diuretic Drugs Capacity Expansion and Future Plans
Table 23. Global Diuretic Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 24. Global Diuretic Drugs Production by Region, 2019-2024, (K Units)
Table 25. Global Diuretic Drugs Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Diuretic Drugs Upstream (Raw Materials)
Table 27. Global Diuretic Drugs Typical Customers
Table 28. Diuretic Drugs Typical Distributors
Table 29. By Type, Global Diuretic Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Application, Global Diuretic Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 31. By Region, Global Diuretic Drugs Market Size, 2019 VS 2024 VS 2030, US$ Million
Table 32. By Region, Global Diuretic Drugs Revenue, 2019-2030, US$ Million
Table 33. By Region, Global Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Table 34. By Country, Global Diuretic Drugs Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million
Table 35. By Country, Global Diuretic Drugs Revenue, 2019-2030, US$ Million
Table 36. By Country, Global Diuretic Drugs Revenue Market Share, 2019-2030
Table 37. By Country, Global Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Table 38. By Country, Global Diuretic Drugs Sales Volume Market Share, 2019-2030
Table 39. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 40. AstraZeneca Diuretic Drugs Models, Specifications and Application
Table 41. AstraZeneca Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. AstraZeneca Company Profile and Main Business
Table 43. AstraZeneca Recent Developments
Table 44. Aurobindo Pharma Company Information, Head Office, Market Area and Industry Position
Table 45. Aurobindo Pharma Diuretic Drugs Models, Specifications and Application
Table 46. Aurobindo Pharma Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Aurobindo Pharma Company Profile and Main Business
Table 48. Aurobindo Pharma Recent Developments
Table 49. Glaxosmithkline Company Information, Head Office, Market Area and Industry Position
Table 50. Glaxosmithkline Diuretic Drugs Models, Specifications and Application
Table 51. Glaxosmithkline Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Glaxosmithkline Company Profile and Main Business
Table 53. Glaxosmithkline Recent Developments
Table 54. Meda Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 55. Meda Pharmaceuticals Diuretic Drugs Models, Specifications and Application
Table 56. Meda Pharmaceuticals Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Meda Pharmaceuticals Company Profile and Main Business
Table 58. Meda Pharmaceuticals Recent Developments
Table 59. Roche Company Information, Head Office, Market Area and Industry Position
Table 60. Roche Diuretic Drugs Models, Specifications and Application
Table 61. Roche Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Roche Company Profile and Main Business
Table 63. Roche Recent Developments
Table 64. Bayer Company Information, Head Office, Market Area and Industry Position
Table 65. Bayer Diuretic Drugs Models, Specifications and Application
Table 66. Bayer Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 67. Bayer Company Profile and Main Business
Table 68. Bayer Recent Developments
Table 69. Bristol-Myers Squibb Compan Company Information, Head Office, Market Area and Industry Position
Table 70. Bristol-Myers Squibb Compan Diuretic Drugs Models, Specifications and Application
Table 71. Bristol-Myers Squibb Compan Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 72. Bristol-Myers Squibb Compan Company Profile and Main Business
Table 73. Bristol-Myers Squibb Compan Recent Developments
Table 74. yCipla Company Information, Head Office, Market Area and Industry Position
Table 75. yCipla Diuretic Drugs Models, Specifications and Application
Table 76. yCipla Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 77. yCipla Company Profile and Main Business
Table 78. yCipla Recent Developments
Table 79. F.Hoffmann-La Roche Company Information, Head Office, Market Area and Industry Position
Table 80. F.Hoffmann-La Roche Diuretic Drugs Models, Specifications and Application
Table 81. F.Hoffmann-La Roche Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 82. F.Hoffmann-La Roche Company Profile and Main Business
Table 83. F.Hoffmann-La Roche Recent Developments
Table 84. Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
Table 85. Fresenius Kabi Diuretic Drugs Models, Specifications and Application
Table 86. Fresenius Kabi Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 87. Fresenius Kabi Company Profile and Main Business
Table 88. Fresenius Kabi Recent Developments
Table 89. GSK plc Company Information, Head Office, Market Area and Industry Position
Table 90. GSK plc Diuretic Drugs Models, Specifications and Application
Table 91. GSK plc Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 92. GSK plc Company Profile and Main Business
Table 93. GSK plc Recent Developments
Table 94. Hikma Pharmaceuticals PLC Company Information, Head Office, Market Area and Industry Position
Table 95. Hikma Pharmaceuticals PLC Diuretic Drugs Models, Specifications and Application
Table 96. Hikma Pharmaceuticals PLC Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 97. Hikma Pharmaceuticals PLC Company Profile and Main Business
Table 98. Hikma Pharmaceuticals PLC Recent Developments
Table 99. Mylan Company Information, Head Office, Market Area and Industry Position
Table 100. Mylan Diuretic Drugs Models, Specifications and Application
Table 101. Mylan Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 102. Mylan Company Profile and Main Business
Table 103. Mylan Recent Developments
Table 104. Novartis Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 105. Novartis Pharmaceuticals Diuretic Drugs Models, Specifications and Application
Table 106. Novartis Pharmaceuticals Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 107. Novartis Pharmaceuticals Company Profile and Main Business
Table 108. Novartis Pharmaceuticals Recent Developments
Table 109. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 110. Pfizer Diuretic Drugs Models, Specifications and Application
Table 111. Pfizer Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 112. Pfizer Company Profile and Main Business
Table 113. Pfizer Recent Developments
Table 114. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 115. Sanofi Diuretic Drugs Models, Specifications and Application
Table 116. Sanofi Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 117. Sanofi Company Profile and Main Business
Table 118. Sanofi Recent Developments
Table 119. Teva Pharmaceutical lndustries Company Information, Head Office, Market Area and Industry Position
Table 120. Teva Pharmaceutical lndustries Diuretic Drugs Models, Specifications and Application
Table 121. Teva Pharmaceutical lndustries Diuretic Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 122. Teva Pharmaceutical lndustries Company Profile and Main Business
Table 123. Teva Pharmaceutical lndustries Recent Developments
List of Figure
Figure 1. Diuretic Drugs Picture
Figure 2. By Revenue, Global Diuretic Drugs Market Size and Forecast, 2019-2030, US$ Million
Figure 3. By Sales Volume, Global Diuretic Drugs Market Size and Forecast, 2019-2030, (K Units)
Figure 4. Global Diuretic Drugs Price Trend, 2019-2030, (US$/Unit)
Figure 5. By Revenue, China Diuretic Drugs Market Size and Forecast, 2019-2030, US$ million
Figure 6. By Sales Volume, China Diuretic Drugs Market Size and Forecast, 2019-2030, (K Units)
Figure 7. China Diuretic Drugs Price Trend, 2019-2030 (US$/Unit)
Figure 8. By Revenue, China Diuretic Drugs Share of Global Market, 2019-2030
Figure 9. By Sales Volume, China Diuretic Drugs Share of Global Market, 2019-2030
Figure 10. Global Diuretic Drugs Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 11. Global Diuretic Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023
Figure 12. China Diuretic Drugs Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 13. China Diuretic Drugs Key Participants, Market Share, 2021 VS 2023 VS 2023
Figure 14. China Diuretic Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024
Figure 15. Chinese Local Players, Proportion of Diuretic Drugs Domestic VS Export, 2023
Figure 16. Global Diuretic Drugs Capacity, Production and Capacity Utilization, 2019-2030
Figure 17. Global Diuretic Drugs Capacity Market Share by Region, 2023 VS 2029
Figure 18. Global Diuretic Drugs Production Market Share & Forecast by Region, 2019-2030
Figure 19. Diuretic Drugs Industry Chain
Figure 20. Diuretic Drugs Procurement Model
Figure 21. Diuretic Drugs Sales Model
Figure 22. Diuretic Drugs Sales Channels, Direct Sales and Distribution
Figure 23. Carbonic Anhydrase Inhibitors
Figure 24. Loop Diuretics
Figure 25. Osmotic Diuretics
Figure 26. Potassium-sparing Diuretics
Figure 27. Thiazide Diuretics
Figure 28. By Type, Global Diuretic Drugs Revenue, 2019-2030, US$ Million
Figure 29. By Type, Global Diuretic Drugs Revenue Market Share, 2019-2030
Figure 30. By Type, Global Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Figure 31. By Type, Global Diuretic Drugs Sales Volume Market Share, 2019-2030
Figure 32. By Type, Global Diuretic Drugs Price, 2019-2030, (US$/Unit)
Figure 33. Hospital Pharmacies
Figure 34. Retail Pharmacies
Figure 35. Online Pharmacies
Figure 36. By Application, Global Diuretic Drugs Revenue, 2019-2030, US$ Million
Figure 37. By Application, Global Diuretic Drugs Revenue Market Share, 2019-2030
Figure 38. By Application, Global Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Figure 39. By Application, Global Diuretic Drugs Sales Volume Market Share, 2019-2030
Figure 40. By Application, Global Diuretic Drugs Price, 2019-2030, (US$/Unit)
Figure 41. By Region, Global Diuretic Drugs Revenue Market Share, 2019-2030
Figure 42. By Region, Global Diuretic Drugs Sales Volume Market Share, 2019-2030
Figure 43. North America Diuretic Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 44. By Country, North America Diuretic Drugs Revenue Market Share, 2023
Figure 45. Europe Diuretic Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 46. By Country, Europe Diuretic Drugs Revenue Market Share, 2023
Figure 47. Asia Pacific Diuretic Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 48. By Country/Region, Asia Pacific Diuretic Drugs Revenue Market Share, 2023
Figure 49. South America Diuretic Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 50. By Country, South America Diuretic Drugs Revenue Market Share, 2023
Figure 51. Middle East & Africa Diuretic Drugs Revenue & Forecasts, 2019-2030, US$ Million
Figure 52. U.S. Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Figure 53. By Company, U.S. Diuretic Drugs Market Share, 2023
Figure 54. By Type, U.S. Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 55. By Application, U.S. Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 56. Europe Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Figure 57. By Company, Europe Diuretic Drugs Market Share, 2023
Figure 58. By Type, Europe Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 59. By Application, Europe Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 60. China Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Figure 61. By Company, China Diuretic Drugs Market Share, 2023
Figure 62. By Type, China Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 63. By Application, China Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 64. Japan Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Figure 65. By Company, Japan Diuretic Drugs Market Share, 2023
Figure 66. By Type, Japan Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 67. By Application, Japan Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 68. South Korea Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Figure 69. By Company, South Korea Diuretic Drugs Market Share, 2023
Figure 70. By Type, South Korea Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 71. By Application, South Korea Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 72. Southeast Asia Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Figure 73. By Company, Southeast Asia Diuretic Drugs Market Share, 2023
Figure 74. By Type, Southeast Asia Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 75. By Application, Southeast Asia Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 76. India Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Figure 77. By Company, India Diuretic Drugs Market Share, 2023
Figure 78. By Type, India Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 79. By Application, India Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 80. Middle East & Asia Diuretic Drugs Sales Volume, 2019-2030, (K Units)
Figure 81. By Company, Middle East & Asia Diuretic Drugs Market Share, 2023
Figure 82. By Type, Middle East & Asia Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 83. By Application, Middle East & Asia Diuretic Drugs Sales Volume Market Share, 2023 VS 2029
Figure 84. Research Methodology
Figure 85. Breakdown of Primary Interviews
Figure 86. Bottom-up Approaches
Figure 87. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|